MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX

Kiss, I; Mlcochova, J; Souckova, K; Fabian, P; Poprach, A; Halamkova, J; Svoboda, M; Vyzula, R; Slaby, O

Slaby, O (reprint author), Masaryk Univ, Dept Mol Med, Cent European Inst Technol, Univ Campus Bohunice,Kamenice 5, Brno 62500, Czech Republic.

ONCOLOGY LETTERS, 2017; 14 (1): 743

Abstract

Bevacizumab is a humanized anti-vascular endothelial growth factor monoclonal antibody, used in combination with a oxaliplatin-based chemotherapy in t......

Full Text Link